The survey of subtotal resection group was significantlyshorter than the other TR group.Conclusion: As a result, recovery was inversely increased with residual tumor volume
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: Glial tumors are treated with a multidisciplinary team approach including specialists in brain surgery, radiology, pathology, radiation oncology and medical oncology.
📊
Key Findings & Data:The aim of this study is to investigate the relationshipbetween the residual tumor volume and survival of the patients who were operated with the diagnosis of intracranialglial tumor in the last 5 years.Methods: Of 49 patients, 30 underwent total resection and 19 underwent subtotal resection.Results: The average surveys of total resection were 13.6 (6-32 months) months. 4 of 6 patients with anaplastic astrocytoma survived and the mean survey was 26.5 (4-45) months.
💡
Conclusion & Impact:The survey of subtotal resection group was significantlyshorter than the other TR group.Conclusion: As a result, recovery was inversely increased with residual tumor volume
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objectives: Glial tumors are treated with a multidisciplinary team approach including specialists in brain surgery, radiology, pathology, radiation oncology and medical oncology. Surgery is one of the main treatment options. However,the effect of resection volume on prognosis is still uncertain. The aim of this study is to investigate the relationshipbetween the residual tumor volume and survival of the patients who were operated with the diagnosis of intracranialglial tumor in the last 5 years.Methods: Of 49 patients, 30 underwent total resection and 19 underwent subtotal resection.Results: The average surveys of total resection were 13.6 (6-32 months) months. 4 of 6 patients with anaplastic astrocytoma survived and the mean survey was 26.5 (4-45) months. The survey of subtotal resection group was significantlyshorter than the other TR group.Conclusion: As a result, recovery was inversely increased with residual tumor volume
🔖
Cite This Article
BULDUK, E. B., ERCAN, S., ATAİZİ, Z. S., ATAİZİ, F. (2022). Effects of Total and Subtotal Glial Tumor Resection on Survival. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 1, 73–77. https://ajindex.com/articles/508640
Bush NAO, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurgical review 2017; 40:1–14
Dolecek TA, Propp JM, Stroup NE, Kruchko C. Descriptive epidemiology of pituitary tumors in the United States. Journal of neurosurgery 2012;121
Ostrom QT, Gittleman H, Stetson L, Virk SM, Barnholtz-Sloan JS. Epidemiology of gliomas. Cancer treatment and research 2015;163:1–14
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer 2015;136:E359-86
Delgado-Lopez PD, Corrales-Garcia EM. Survival in glioblastoma: a review on the impact of treatment modalities. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2016;18:1062–1071
Wen PY, Kesari S. Malignant gliomas in adults. The New England journal of medicine 2008;359:492–507
Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, et al. European Association for NeuroOncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. The Lancet. Oncology 2017;18:e315–e329
Ahmed R, Oborski MJ, Hwang M, Lieberman FS, Mountz JM. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer management and research 2014;6:149–170
Butowski NA. Epidemiology and diagnosis of brain tumors. Continuum (Minneapolis, Minn.) 2015; 21:301–313
Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1988;6:338–343
Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, et al. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. Journal of neurosurgery 2014;121:1115–1123
Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, et al. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro-Oncology 2014; 16:113–122
Dewitt JC, Mock A, Louis DN. The 2016 WHO classifi